Why GLP-1 coverage decisions are getting more complex Deciding whether to cover GLP-1s for weight loss can be challenging, especially given the significant costs involved
Ni Lochlainn M, Bowyer RCE, Moll JM, Garcia MP, Wadge S, Baleanu AF, Nessa A, Sheedy A, Akdag G, Hart D, et al
This is not a case of weak or conflicting evidence that a reader must weigh
Stop eating as soon as you feel full, as this class of medication slows gastric emptying
Its first Phase 3 readout reported roughly 28.7% weight reduction at 12 mg over 68 weeks 5 a meaningful six-percentage-point ceiling advantage over tirzepatides SURMOUNT-1 peak of 22.5% over 72 weeks 13
Pro Tip (from estheticians): For enhanced results, apply after cleansing and before heavier creams and be consistent